美国非处方连续血糖监测 (OTC) 设备市场规模、份额和趋势分析报告：按用户、应用、销售管道和细分市场预测，2025 年至 2033 年

市场规模与趋势：

美国OTC 连续血糖监测 (CGM) 设备市场预计在 2024 年达到 4,861 万美元，到 2033 年将达到 9,352 万美元，2025 年至 2033 年的复合年增长率为 8.0%。

生活健康设备的日益普及，包括用于更便捷糖尿病管理的连续血糖监测 (CGM)，以及可穿戴健康工具的便利使用，正在推动需求成长。例如，到 2024 年，超过 44% 的美国成年人将使用穿戴式健康工具进行疾病监测和管理。

此外，预计未来5到10年，美国老年族群的采用率将达到50%。日益增长的老年人口和久坐不动的生活方式加剧了疾病负担，因此迫切需要开发像CGM这样的先进监测解决方案。此外，医疗保健基础设施的不断扩大以及透过非处方笺电商管道分销CGM设备，将促进人们获取这些设备。感测器精度、应用程式整合和数据共用等技术进步将进一步推动都市区和半都市区的市场成长。

截至2025年，美国将有约3,800万成年人被诊断出患有糖尿病，占美国成年人口总数的11.5%。此外，美国约有9700万成年人处于糖尿病前期。肥胖和久坐不动的生活方式是导致糖尿病流行的主要因素。 2型糖尿病患者数量的持续激增以及人们对早期诊断意识的不断提高，可能会推动美国对非处方动态血糖监测（OTC CGM）设备的需求。

新推出的非处方 (OTC) 动态血糖监测 (CGM) 设备提案用于未使用胰岛素的第 2 型糖尿病患者。由于处方笺CGM 不在第 2 型糖尿病保险范围内，因此 OTC 设备可以提供协助。 OTC CGM 价格实惠，无需处方笺即可购买。虽然 OTC CGM 不在保险范围内，但 HAS/FSA 基金通常可以接受。

目录

第一章调查方法与范围

第二章执行摘要

第 3 章美国OTC 连续血糖监测 (CGM) 设备市场变数、趋势与范围

• 市场介绍/电网展望
• 市场规模和成长前景
• 市场动态
  • 市场驱动因素分析
  • 市场限制因素分析
• 美国OTC CGM设备市场分析工具
  • 波特分析
  • PESTEL分析

第四章美国OTC连续血糖监测（CGM）设备市场用户估计与趋势分析

• 细分仪表板
• 美国OTC CGM设备市场用户波动
• 2024 年至 2033 年美国OTC CGM 设备市场规模及使用者趋势分析
• 非糖尿病患者
• 糖尿病前期
• 糖尿病患者

第五章美国OTC连续血糖监测（CGM）设备市场应用预测与趋势分析

• 细分仪表板
• 美国OTC CGM设备市场应用波动
• 2024-2033 年美国OTC CGM 设备市场规模及应用趋势分析
• 生活方式健康
• 糖尿病监测

第六章美国OTC连续血糖监测（CGM）设备市场依销售管道的估计与趋势分析

• 细分仪表板
• 美国OTC CGM设备市场按销售管道的波动
• 美国OTC CGM 设备市场规模与销售管道趋势分析（2025-2033 年）
• 公司网站
• 零售商

第七章 竞争态势

• 主要市场参与企业的近期趋势和影响分析
• 公司分类
• 公司热图分析
• 公司简介
  • Abbott Laboratories
  • Dexcom Inc.

Market Size & Trends:

The U.S. OTC continuous glucose monitoring devices market size was estimated at USD 48.61 million in 2024 and is expected to reach USD 93.52 million by 2033, growing at a CAGR of 8.0% from 2025 to 2033. The rising adoption of lifestyle wellness devices, including continuous glucose monitoring (CGM) to ease diabetes management, and the easy access to wearable health tools are fueling demand. For instance, in 2024, more than 44% of American adults adopted wearable health tools for disease monitoring and management.

Additionally, in the coming 5 to 10 years, the adoption rate is expected to reach 50% among elderly Americans. The growing geriatric population and sedentary lifestyles contribute to the disease burden, imposing the development of advanced monitoring solutions such as CGM. Furthermore, expanding healthcare infrastructure and distribution of CGM devices through e-commerce without a prescription would ease accessibility. Technological advancements like sensor accuracy, app integration, and data sharing further support market growth across urban and semi-urban areas.

As of 2025, nearly 38 million American adults are diagnosed with diabetes, marking 11.5% of the total adult population in the U.S. Furthermore, around 97 million adults are prediabetic in the country. Obesity and a sedentary lifestyle are the major contributing factors to the prevalence of diabetes. Continued surge in type 2 diabetes cases and growing awareness of early diagnoses are likely to boost the demand for OTC CGM devices in the U.S.

Newly introduced OTC CGM devices are suggested to be used by type 2 diabetes that are not on insulin. As type 2 diabetes does not get the insurance for prescription CGM, OTC comes in as a help. OTC CGM sells at an affordable rate and without a prescription. Although the OTC CGMs are not covered by insurance, the HAS/FSA funds are generally accepted.

U.S. OTC Continuous Glucose Monitoring Devices Market Report Segmentation

This report forecasts revenue growth at country levels and analyzes the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. OTC continuous glucose monitoring devices market report based on user, application, and sales channel:

• User Outlook (Revenue, USD Million, 2021 - 2033)
  • Non-diabetic
  • Prediabetic
  • Diabetic
• Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Lifestyle Wellness
  • Diabetes Monitoring
• Sales Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Company Website
  • Retailers

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Information or Data Analysis
  • 1.3.3. Market Formulation & Data Visualization
  • 1.3.4. Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. OTC CGM Devices Market Variables, Trends, & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Market Size and Growth Prospects (USD Million)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
  • 3.3.2. Market Restraints Analysis
• 3.4. U.S. OTC CGM Devices Market Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1. Bargaining power of the suppliers
    • 3.4.1.2. Bargaining power of the buyers
    • 3.4.1.3. Threats of substitution
    • 3.4.1.4. Threats from new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic and Social landscape
    • 3.4.2.3. Technological landscape
    • 3.4.2.4. Environmental landscape
    • 3.4.2.5. Legal landscape

Chapter 4. U.S. OTC CGM Devices Market: User Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. OTC Continuous Glucose Monitoring (CGM) Devices Market User Movement Analysis
• 4.3. U.S. OTC Continuous Glucose Monitoring (CGM) Devices Market Size & Trend Analysis, by User, 2024 to 2033 (USD Million)
• 4.4. Non-diabetic
  • 4.4.1. Non-diabetic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Prediabetic
  • 4.5.1. Prediabetic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Diabetic
  • 4.6.1. Diabetic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. OTC CGM Devices Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. OTC Continuous Glucose Monitoring (CGM) Devices Market Application Movement Analysis
• 5.3. U.S. OTC Continuous Glucose Monitoring (CGM) Devices Market Size & Trend Analysis, by Application, 2024 to 2033 (USD Million)
• 5.4. Lifestyle Wellness
  • 5.4.1. Lifestyle wellness market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 5.5. Diabetes Monitoring
  • 5.5.1. Diabetes monitoring market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. OTC CGM Devices Market: Sales Channel Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. OTC Continuous Glucose Monitoring Devices Market Sales Channel Movement Analysis
• 6.3. U.S. OTC Continuous Glucose Monitoring Devices Market Size & Trend Analysis, by Sales Channel, 2025 to 2033 (USD Million)
• 6.4. Company Website
  • 6.4.1. Company website Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Retailers
  • 6.5.1. Retailers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis by Key Market Participants
• 7.2. Company Categorization
• 7.3. Company Heat Map Analysis
• 7.4. Company Profiles
  • 7.4.1. Abbott Laboratories
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Dexcom Inc.
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product benchmarking
    • 7.4.2.4. Strategic initiatives

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 U.S. OTC continuous glucose monitoring devices by user, 2021 - 2033 (USD Million)
• Table 4 U.S. OTC continuous glucose monitoring devices by application, 2021 - 2033 (USD Million)
• Table 5 U.S. OTC continuous glucose monitoring devices by sales channel, 2021 - 2033 (USD Million)
• Table 6 Participant's overview
• Table 7 Financial performance
• Table 8 Key companies undergoing expansions
• Table 09 Key companies undergoing acquisitions
• Table 10 Key companies undergoing collaborations
• Table 11 Key companies launching new products
• Table 12 Key companies undergoing partnerships
• Table 13 Key companies undertaking other strategies

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 U.S. OTC CGM devices market segmentation
• Fig. 7 Market driver analysis (Current & future impact)
• Fig. 8 Market restraint analysis (Current & future impact)
• Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 10 Porter's Five Forces Analysis
• Fig. 11 U.S. OTC continuous glucose monitoring devices user outlook key takeaways (USD Million)
• Fig. 12 U.S. OTC continuous glucose monitoring devices market user movement analysis 2024 & 2033 (USD Million)
• Fig. 13 Non-diabetic market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 14 Prediabetes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 15 Diabetes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 16 U.S. OTC continuous glucose monitoring devices application outlook key takeaways (USD Million)
• Fig. 17 U.S. OTC continuous glucose monitoring devices market application movement analysis 2024 & 2033 (USD Million)
• Fig. 18 Lifestyle wellness market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 19 Diabetes monitoring market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 20 U.S. OTC continuous glucose monitoring devices sales channel outlook key takeaways (USD Million)
• Fig. 21 U.S. OTC continuous glucose monitoring devices sales channel analysis 2024 & 2033 (USD Million)
• Fig. 22 Company website market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 23 Retailers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 24 Heat map analysis
• Fig. 25 Market participant categorization
• Fig. 26 U.S. OTC continuous glucose monitoring devices market share analysis, 2024
• Fig. 27 Strategy framework